Iranian Red Crescent Medical Journal

Published by: Kowsar

Clustering Asian Countries According to the Trend of liver cancer Mortality Rates: an Application of Growth Mixture Models

Maryam Salari 1 , Anoshirvan Kazemnejad 2 , * and Farid Zayeri 3
Authors Information
1 Ph.D Student, Biostatistics, Department of Biostatistics, Faculty of Medical Sciences, Tarbiat Modares University, Tehran, Iran
2 Professor, Department of Biostatistics, Faculty of Medical Sciences, Tarbiat Modares University, Tehran, Iran
3 Associate Professor, Department of Biostatistics, Member of Proteomics Research Center, School of Paramedical Sciences, Shahid Beheshti University of Medical Sciences, Tehran, Iran
Article information
  • Iranian Red Crescent Medical Journal: August 2017, 19 (8); e15107
  • Published Online: July 24, 2017
  • Article Type: Research Article
  • Received: December 6, 2016
  • Revised: February 28, 2017
  • Accepted: March 28, 2017
  • DOI: 10.5812/ircmj.15107

To Cite: Salari M, Kazemnejad A, Zayeri F. Clustering Asian Countries According to the Trend of liver cancer Mortality Rates: an Application of Growth Mixture Models, Iran Red Crescent Med J. 2017 ;19(8):e15107. doi: 10.5812/ircmj.15107.

Copyright © 2017, Iranian Red Crescent Medical Journal. This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License ( which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited.
1. Background
2. Methods
3. Results
4. Discussion
  • 1. Lee B, Konen J, Wilkinson S, Marcus AI, Jiang Y. Local alignment vectors reveal cancer cell-induced ECM fiber remodeling dynamics. Sci Rep. 2017; 7: 39498[DOI][PubMed]
  • 2. Arabsalmani M, Mohammadian-Hafshejani A, Ghoncheh M, Hadadian F, Towhidi F, Vafaee K, et al. Incidence and mortality of kidney cancers, and human development index in Asia; a matter of concern. J Nephropathol. 2017; 6(1): 30-42[DOI][PubMed]
  • 3. Wang P, Wang M, Li S, Ma L, Xi S, He J. Association of the MDM2 SNP285 Polymorphism with Cancer Susceptibility: A Meta-Analysis. Dis Markers. 2016; 2016: 4585484[DOI][PubMed]
  • 4. Costello LC, Franklin RB. Decreased zinc in the development and progression of malignancy: an important common relationship and potential for prevention and treatment of carcinomas. Expert Opin Ther Targets. 2017; 21(1): 51-66[DOI][PubMed]
  • 5. Wen X, Lu F, Liu S. Prognostic value of p53 mutation for poor outcome of Asian primary liver cancer patients: evidence from a cohort study and meta-analysis of 988 patients. Onco Targets Ther. 2016; 9: 7425-33[DOI][PubMed]
  • 6. Tian C, Yao S, Liu L, Ding Y, Ye Q, Dong X, et al. Klf4 inhibits tumor growth and metastasis by targeting microRNA-31 in human hepatocellular carcinoma. Int J Mol Med. 2017; 39(1): 47-56[DOI][PubMed]
  • 7. Cong WM, Bu H, Chen J, Dong H, Zhu YY, Feng LH, et al. Practice guidelines for the pathological diagnosis of primary liver cancer: 2015 update. World J Gastroenterol. 2016; 22(42): 9279-87[DOI][PubMed]
  • 8. Best J, Schotten C, Theysohn JM, Wetter A, Muller S, Radunz S, et al. Novel implications in the treatment of hepatocellular carcinoma. Ann Gastroenterol. 2017; 30(1): 23-32[DOI][PubMed]
  • 9. Zhang H, Zhou D, Ying M, Chen M, Chen P, Chen Z, et al. Expression of Long Non-Coding RNA (lncRNA) Small Nucleolar RNA Host Gene 1 (SNHG1) Exacerbates Hepatocellular Carcinoma Through Suppressing miR-195. Med Sci Monit. 2016; 22: 4820-9[DOI][PubMed]
  • 10. Alkhalili E, Greenbaum A, Luo L, Rodriguez R, Caldwell K, Estrada OM, et al. Viral hepatitis status does not affect survival in patients with hepatocellular carcinoma. Ann Gastroenterol. 2017; 30(1): 101-5[DOI][PubMed]
  • 11. Jeric I, Maurer G, Cavallo AL, Raguz J, Desideri E, Tarkowski B, et al. A cell-autonomous tumour suppressor role of RAF1 in hepatocarcinogenesis. Nat Commun. 2016; 7: 13781[DOI][PubMed]
  • 12. Zhang G, Fang X, Guo X, Li L, Luo R, Xu F, et al. The oyster genome reveals stress adaptation and complexity of shell formation. Nature. 2012; 490(7418): 49-54[DOI][PubMed]
  • 13. Liang P, Huang C, Liang SX, Li YF, Huang SX, Lian ZP, et al. Effect of CyberKnife stereotactic body radiation therapy for hepatocellular carcinoma on hepatic toxicity. Onco Targets Ther. 2016; 9: 7169-75[DOI][PubMed]
  • 14. Lee K, Lee KB, Yi NJ, Suh KS, Jang JJ. Prognosis of Hepatocellular Carcinoma after Liver Transplantation: Comparative Analysis with Partial Hepatectomy. J Pathol Transl Med. 2017; 51(1): 79-86[DOI][PubMed]
  • 15. Kawaguchi Y, Honda G, Endo I, Cherqui D, Kokudo N. Current Technical Issues for Surgery of Primary Liver Cancer. Liver Cancer. 2016; 6(1): 51-8[DOI][PubMed]
  • 16. Zhu W, Zhao Y, Zhou J, Wang X, Pan Q, Zhang N, et al. Monoacylglycerol lipase promotes progression of hepatocellular carcinoma via NF-kappaB-mediated epithelial-mesenchymal transition. J Hematol Oncol. 2016; 9(1): 127[DOI][PubMed]
  • 17. Bawah A, Houle B, Alam N, Razzaque A, Streatfield PK, Debpuur C, et al. The Evolving Demographic and Health Transition in Four Low- and Middle-Income Countries: Evidence from Four Sites in the INDEPTH Network of Longitudinal Health and Demographic Surveillance Systems. PLoS One. 2016; 11(6)[DOI][PubMed]
  • 18. Tran BX, Nguyen LH, Nong VM, Nguyen CT. Health status and health service utilization in remote and mountainous areas in Vietnam. Health Qual Life Outcomes. 2016; 14: 85[DOI][PubMed]
  • 19. Jiang B, Li B, Wang Y, Han B, Wang N, Li Q, et al. The nine-year changes of the incidence and characteristics of metabolic syndrome in China: longitudinal comparisons of the two cross-sectional surveys in a newly formed urban community. Cardiovasc Diabetol. 2016; 15: 84[DOI][PubMed]
  • 20. Pittayapan P. Health Insurance for Cancer Care in Asia: Thailand. Asia Pac J Oncol Nurs. 2016; 3(1): 54-7[DOI][PubMed]
  • 21. Chandra S, Kusum A, Chandra H, Yadav K, Verma SK. Familial Hepatocellular Carcinoma- First Reported Case from India. J Clin Diagn Res. 2016; 10(3)-2[DOI][PubMed]
  • 22. Keefe D, Al Garni A, Villalon A, Hassan A, Kwong D, Li P, et al. Challenges in supportive cancer care: perspectives from the Asia Pacific and Middle East. Support Care Cancer. 2016; 24(11): 4479-81[DOI][PubMed]
  • 23. Si T, Chen Y, Ma D, Gong X, Yang K, Guan R, et al. Preoperative transarterial chemoembolization for resectable hepatocellular carcinoma in Asia area: a meta-analysis of random controlled trials. Scand J Gastroenterol. 2016; 51(12): 1512-9[DOI][PubMed]
  • 24. Zhu RX, Seto WK, Lai CL, Yuen MF. Epidemiology of Hepatocellular Carcinoma in the Asia-Pacific Region. Gut Liver. 2016; 10(3): 332-9[DOI][PubMed]
  • 25. Chassagne F, Rojas Rojas T, Bertani S, Bourdy G, Eav S, Ruiz E, et al. A 13-Year Retrospective Study on Primary Liver Cancer in Cambodia: A Strikingly High Hepatitis C Occurrence among Hepatocellular Carcinoma Cases. Oncology. 2016; 91(2): 106-16[DOI][PubMed]
  • 26.
  • 27. Salzborn S, Davidov E, Reinecke J. Methods, theories, and empirical applications in the social sciences. 2012; [DOI]
  • 28. Muthen B, Shedden K. Finite mixture modeling with mixture outcomes using the EM algorithm. Biometrics. 1999; 55(2): 463-9[PubMed]
  • 29. Muthén B. A general structural equation model with dichotomous, ordered categorical, and continuous latent variable indicators. Psychometrika. 1984; 49(1): 115-32[DOI]
  • 30. Wang J, Wang X. Structural equation modeling: Applications using Mplus. 2012; [DOI]
  • 31. Wang H, Liu J, Hu X, Liu S, He B. Prognostic and Therapeutic Values of Tumor Necrosis Factor-Alpha in Hepatocellular Carcinoma. Med Sci Monit. 2016; 22: 3694-704[DOI][PubMed]
  • 32. Lamarca A, Mendiola M, Barriuso J. Hepatocellular carcinoma: Exploring the impact of ethnicity on molecular biology. Crit Rev Oncol Hematol. 2016; 105: 65-72[DOI][PubMed]
  • 33. Hafeez Bhatti AB, Dar FS, Waheed A, Shafique K, Sultan F, Shah NH. Hepatocellular Carcinoma in Pakistan: National Trends and Global Perspective. Gastroenterol Res Pract. 2016; 2016: 5942306[DOI][PubMed]
  • 34. Xu Y, Chen J, Wang H, Zheng H, Feng D, Zhang A, et al. Perioperative and long-term outcomes of liver resection for hepatitis B virus-related hepatocellular carcinoma without versus with hepatic inflow occlusion: study protocol for a prospective randomized controlled trial. Trials. 2016; 17(1): 492[DOI][PubMed]
  • 35. Hong YM, Yoon KT, Cho M, Kang DH, Kim HW, Choi CW, et al. Trends and Patterns of Hepatocellular Carcinoma Treatment in Korea. J Korean Med Sci. 2016; 31(3): 403-9[DOI][PubMed]
  • 36. Lee EY, Xuan Mai TT, Chang Y, Ki M. Trends of liver cancer and its major risk factors in Korea. Epidemiol Health. 2015; 37[DOI][PubMed]
  • 37. Jemal A, Center MM, DeSantis C, Ward EM. Global patterns of cancer incidence and mortality rates and trends. Cancer Epidemiol Biomarkers Prev. 2010; 19(8): 1893-907[DOI][PubMed]
  • 38. Posuwan N, Wanlapakorn N, Sa-Nguanmoo P, Wasitthankasem R, Vichaiwattana P, Klinfueng S, et al. The Success of a Universal Hepatitis B Immunization Program as Part of Thailand's EPI after 22 Years' Implementation. PLoS One. 2016; 11(3)[DOI][PubMed]
  • 39. Kudo M, Matsui O, Izumi N, Iijima H, Kadoya M, Imai Y, et al. JSH Consensus-Based Clinical Practice Guidelines for the Management of Hepatocellular Carcinoma: 2014 Update by the Liver Cancer Study Group of Japan. Liver Cancer. 2014; 3(3-4): 458-68[DOI][PubMed]
  • 40. Muthen BO. Analysis of longitudinal data using latent variable models with varying parameters. 2011;
  • 41. Chie WC, Blazeby JM, Hsiao CF, Chiu HC, Poon RT, Mikoshiba N, et al. Differences in health-related quality of life between European and Asian patients with hepatocellular carcinoma. Asia Pac J Clin Oncol. 2016; [DOI][PubMed]
Creative Commons License Except where otherwise noted, this work is licensed under Creative Commons Attribution Non Commercial 4.0 International License .

Search Relations:



Create Citiation Alert
via Google Reader

Readers' Comments